Graft Versus Host Disease News and Research

Latest Graft Versus Host Disease News and Research

Patient enrollment completed in Phase 2 clinical trial of orBec for prevention of acute GVHD

Patient enrollment completed in Phase 2 clinical trial of orBec for prevention of acute GVHD

European patent strengthens Soligenix' topically active steroid intellectual property portfolio

European patent strengthens Soligenix' topically active steroid intellectual property portfolio

Osiris Therapeutics reports net income of $2.4M for first-quarter 2010

Osiris Therapeutics reports net income of $2.4M for first-quarter 2010

OSIR reports net income of $15.7M for fourth-quarter 2009 compared to net loss of $7.8M in 2008: MicroStockProfit.com

OSIR reports net income of $15.7M for fourth-quarter 2009 compared to net loss of $7.8M in 2008: MicroStockProfit.com

RayBiotech announces biomarker grant winners

RayBiotech announces biomarker grant winners

Osiris Therapeutics' Prochymal granted FDA Orphan Drug Designation

Osiris Therapeutics' Prochymal granted FDA Orphan Drug Designation

ATIR shows better clinical results in patients receiving mismatched bone marrow transplantation

ATIR shows better clinical results in patients receiving mismatched bone marrow transplantation

RegeneRx Biopharmaceuticals proposes common stock public offering

RegeneRx Biopharmaceuticals proposes common stock public offering

Soligenix's revenues for 2009 increase by 22%

Soligenix's revenues for 2009 increase by 22%

Gentium presents abstract on Defibrotide at EBMT Annual Meeting

Gentium presents abstract on Defibrotide at EBMT Annual Meeting

Researchers develop sensitive measuring system for cGVHD

Researchers develop sensitive measuring system for cGVHD

Phase III trial results of Osiris Therapeutics' Prochymal for GvHD to be presented at BMT Tandem Meeting

Phase III trial results of Osiris Therapeutics' Prochymal for GvHD to be presented at BMT Tandem Meeting

Transition through hemogenic endothelial intermediate necessary for hematopoietic stem cell formation

Transition through hemogenic endothelial intermediate necessary for hematopoietic stem cell formation

Safer bone marrow transplants

Safer bone marrow transplants

Biomarker may enable personalized GVHD treatment for bone marrow transplant patients

Biomarker may enable personalized GVHD treatment for bone marrow transplant patients

Modified blood adult stem-cell transplant regimen reverses sickle cell disease

Modified blood adult stem-cell transplant regimen reverses sickle cell disease

Gentium presents evaluation results of Defibrotide for VOD at the ASH conference

Gentium presents evaluation results of Defibrotide for VOD at the ASH conference

Abstracts on very small embryonic-like stem cells presented at ASH annual meeting

Abstracts on very small embryonic-like stem cells presented at ASH annual meeting

New bone marrow transplantation technique shows prompt immune recovery

New bone marrow transplantation technique shows prompt immune recovery

Bortezomib can improve control of GVHD and immune system recovery

Bortezomib can improve control of GVHD and immune system recovery